ZHANG, GUOXIN – Trademark Portfolio
Entity Type: 01
ZHANG, GUOXIN owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ECTY, NREOY, IKIUTU, DEFLECTAIR, and CUTECATWING. Of these, 7 are registered. The portfolio spans 6 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 21 (Housewares). Headquartered in PUTIAN CITY, FUJIAN PROVINCE.
54-2 DONGHUANG, SHITA VILLAGE, DAITOU
TOWN, XIUYU DISTRICT,
PUTIAN CITY, FUJIAN PROVINCE 351100 , CN
Showing of trademarks Trademarks
Trademark Classifications
ZHANG, GUOXIN's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ZHANG, GUOXIN have?
ZHANG, GUOXIN has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned.
What trademark classes does ZHANG, GUOXIN file in?
ZHANG, GUOXIN files trademarks across 6 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 16 (Paper Goods), Class 25 (Clothing), Class 9 (Computers & Electronics). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are ZHANG, GUOXIN's most well-known trademarks?
ZHANG, GUOXIN's registered trademark portfolio includes well-known marks such as ECTY, NREOY, IKIUTU, DEFLECTAIR, and CUTECATWING. These are among 7 currently registered trademarks in the portfolio.
What is ZHANG, GUOXIN's trademark registration success rate?
ZHANG, GUOXIN has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.